These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12459112)

  • 81. Tacrolimus dosing in mycophenolate-treated patients--can we get away with less?
    de Fijter JW
    Transplantation; 2011 Jul; 92(1):10-1. PubMed ID: 21654351
    [No Abstract]   [Full Text] [Related]  

  • 82. Posterior reversible encephalopathy syndrome (PRES) as a complication of immunosuppressive therapy in renal transplantation in children.
    Hodzic E; Brcic M; Atic M; Halilcevic A; Jasarevic A; Aleckovic-Halilovic M; Trojak D; Atic N; Zulic S; Mehmedovic Z; Iveljic I
    Med Arh; 2014; 68(3):218-20. PubMed ID: 25195358
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Drug interactions of tacrolimus].
    Sumner ME; Albers S; Schmidt KG; Laws HJ; Läer S
    Med Monatsschr Pharm; 2006 Apr; 29(4):139-41. PubMed ID: 16628963
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients.
    Lawsin L; Light JA
    Transplantation; 2003 Jan; 75(1):157-60. PubMed ID: 12544890
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A mismatch between MRI lesions and SPECT hypoperfusion in tacrolimus-related encephalopathy.
    Shijo T; Nishiyama S; Mukai Y; Tateyama M; Kuroda H; Aoki M
    J Neurol Sci; 2016 Aug; 367():308-10. PubMed ID: 27423609
    [No Abstract]   [Full Text] [Related]  

  • 86. Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient.
    Levandoski KA; Girardi NA; Loss MJ
    Dermatol Online J; 2017 May; 23(5):. PubMed ID: 28537866
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Psychosis Associated With Tacrolimus at Therapeutic Serum Levels.
    Uvais NA; Hafeeq B; Gopinathan JC; AzIz F
    Prim Care Companion CNS Disord; 2022 Dec; 24(6):. PubMed ID: 36508727
    [No Abstract]   [Full Text] [Related]  

  • 88. Tacrolimus-induced left ventricular hypertrophy: insights with cardiac magnetic resonance mapping techniques.
    Muršić M; Andreas Z; Christian L; Sabine G; Dietrich B
    Eur Heart J Cardiovasc Imaging; 2021 May; 22(6):e78. PubMed ID: 33200194
    [No Abstract]   [Full Text] [Related]  

  • 89. Severe left ventricular hypertrophy due to immunosuppresive treatment after heart transplantation: A rare complication.
    González Saldivar H; Vicent Alaminos L; Fernández-Yáñez J
    Med Clin (Barc); 2018 Apr; 150(7):286. PubMed ID: 29089116
    [No Abstract]   [Full Text] [Related]  

  • 90. Glucose metabolic disorder after transplantation.
    van Hooff JP; Christiaans MH; van Duijnhoven EM
    Am J Transplant; 2007 Jun; 7(6):1435-6. PubMed ID: 17511670
    [No Abstract]   [Full Text] [Related]  

  • 91. New Immunosuppressive Strategies to Achieve Better Compliance and Results.
    Hafez MH
    Exp Clin Transplant; 2022 May; 20(Suppl 3):17-20. PubMed ID: 35570594
    [No Abstract]   [Full Text] [Related]  

  • 92. Pain management in a patient with medication allergies.
    Cancer Pract; 1998; 6(1):8-10. PubMed ID: 9460321
    [No Abstract]   [Full Text] [Related]  

  • 93. [Cardiac hypertrophy in kidney transplanted female patient treated with tacrolimus].
    Romero Tarín E; Martín Fernández M; Simarro García C; Brime Casanueva JI
    Med Clin (Barc); 2002 Nov; 119(18):715. PubMed ID: 12459112
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.